All articles by Andrew Turley – Page 9
-
News
Taming osmosis for steady drug delivery
A German start up has developed a disposable infusion pump that uses osmosis instead of electrical power
-
News
European fracking boom 'doubtful'
The high surface activity needed for shale gas extraction is likely to put off Europeans, says the boss of Shell Chemical
-
News
A polymer plug for blood vessels
The makers of the gel say it is less damaging than using clamps to block blood vessels for surgery
-
News
Interview: Gilles Cottier
The president of SAFC has set ambitious growth targets that he plans to meet by sticking close to his customers
-
News
Making drugs in Ireland
An educated workforce and low tax means the pharma industry is still keen to invest despite the economic upheaval
-
News
First Pfizer spinout at Sandwich
The seven person company will broker the outsourcing process for client drug companies
-
News
Unreported emissions linked to EU chemical industry
A top down analysis of atmospheric HFC-23 suggests that countries are releasing up to 140 per cent more than they are reporting
-
News
Chemical activism targets big clothing brands
Greenpeace has provoked promises from Nike that it will take action on supply chain chemicals
-
News
DuPont halts sale of wayward herbicide
Complaints of damage to trees have led the US chemical major to suspend sales of Imprelis, approved in the US in August last year
-
News
Dow and Aramco launch $20bn chemical project
The companies have approved a massive integrated chemical complex to be built in Jubail, Saudi Arabia
-
News
UK report criticises forensic science move
A report from the UK Science and Technology Committee says the closure of the Forensic Science Service should be pushed back at least six months
-
News
Pfizer to keep 350 jobs at Sandwich
Pfizer has said it will retain some activity at its site at Sandwich, UK, to encourage fresh commercial interest in the site and its assets
-
News
A textile bag for bomb blast protection
An unconventional approach to aircraft safety that incorporates fluids that thicken under impact is being tested
-
News
Chemical industry fears over UK emissions plans
Plans to halve emissions by 2050 could jeopardise a greener future, the industry says
-
News
New data reignites eye drug debate
The much cheaper but unlicensed option is as effective, according to interim results, but safety remains a talking point
-
News
Teva sidelines Valeant with $6.8bn Cephalon bid
The move increases product diversity at the generics giant and strengthens its branded products portfolio
-
News
Solvay and Rhodia to form European giant
The deal marks the end of a period of 'bolt on' buying as companies begin to diversify again, experts say
-
News
Pfizer sells capsule business for $2.4bn
The divestment could be the first of several intended to bring about a smaller but fitter company
-
News
Court halts EU patent progress
The 'enhanced cooperation' route to an EU-level patent conflicts with EU law
-
Feature
SizingItUp
Andrew Turley takes a tour of the latest tools for particle sizing, and finds that the answer depends very much on the way you ask the question